| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.099 | 0.04 |